To the full analysis
Buyback calculator for Hansoh Pharmaceutical Group
Hansoh Pharmaceutical Group stock: key metrics
3692.HKHansoh Pharmaceutical Group had an operating margin of 36% and a return on invested capital (ROIC) of 98.6% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2016 | 92.7% | 33.3% | 27.2% |
| 2017 | 92.6% | 31.2% | 25.8% |
| 2018 | 92.2% | 30.0% | 24.6% |
| 2019 | 91.5% | 32.0% | 29.4% |
| 2020 | 90.8% | 31.9% | 29.6% |
| 2021 | 91.2% | 29.2% | 27.3% |
| 2022 | 90.7% | 28.5% | 27.5% |
| 2023 | 89.8% | 28.1% | 32.4% |
| 2024 | 91.0% | 32.9% | 35.7% |
| 2025 | 89.9% | 36.0% | 37.0% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2016 | 79.9% | 52.9% | 30.6% |
| 2017 | 40.9% | 148.6% | 27.2% |
| 2018 | 145.1% | 49.7% | 22.6% |
| 2019 | 19.6% | 28.5% | 13.1% |
| 2020 | 14.4% | 14.6% | 12.4% |
| 2021 | 13.5% | 52.0% | 10.0% |
| 2022 | 11.4% | 45.4% | 8.6% |
| 2023 | 12.7% | 46.5% | 9.9% |
| 2024 | 15.2% | 65.1% | 13.8% |
| 2025 | 15.7% | 98.6% | 13.9% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = HK$7.8782, $1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 29 Feb 2024)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.